PMC8297709_01
Case presentation. (A) Timeline of disease diagnosis and treatment. (B) Magnetic resonance imaging (MRI) from 2018 to 2020 (from left to right) in T2WI. The red circle indicates the damaged lesion and the white arrow indicates the tumor site.
fimmu-12-682262-g001.jpg
PMC8297709_01_fimmu-12-682262-g001.jpg
f1
An overview of the course of the disease can refer to  Figure 1 .
PET-CMR images showed myocardial inflammatory damage. (A) MR image indicated the physiological tissue structure of the heart. The red circle represented the left ventricle. The figure in the lower right corner was the image cut surface. (B) PET image indicated the uptake of the contrast media 18F-FDG. The red circle represented the increased intake. (C) Fusion image of PET and MR, which visually displayed myocardial inflammatory damage in the left ventricle. PET, positron emission computed tomography; 18F-FDG, 18F-flurodeoxyglucose.
fimmu-12-682262-g002.jpg
PMC8297709_01_fimmu-12-682262-g002.jpg
f2
Positron emission computed tomography-cardiovascular magnetic resonance imaging (PET-CMR) demonstrated myocardial inflammatory and traumatic changes ( Figure 2 ).
Changes in important indicators during the course of the disease. Changes in myocardial enzymes (A), renal function and liver function (B). Take the value of the routine examination before the onset as the base.
fimmu-12-682262-g003.jpg
PMC8297709_01_fimmu-12-682262-g003.jpg
f3
Important indicators were regularly reviewed throughout the following treatment process ( Figure 3 ).